Model
Edge
Avadel Pharmaceuticals PLC
AVDL
Filing Type
8-K
Filing Date
2/11/2026
Updated
2/12/26, 5:40 AM
Filing
8-K
Earnings Release
Exhibits
8-K
End of Material Contract, Completing Asset Acquisition or Sale, Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Material Modifications to Rights of Security Holders, Change in Company Ownership, Changes in Board, Management or Compensation, Amendments to Articles of Incorporation or Bylaws, Reg. FD
EX-3.1
EXHIBIT 3.1
EX-99.1
End of Material Contract, Completing Asset Acquisition or Sale, Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Material Modifications to Rights of Security Holders, Change in Company Ownership, Changes in Board, Management or Compensation, Amendments to Articles of Incorporation or Bylaws, Reg. FD